君實生物(688180.SH):接入Deepseek後,進一步試點營銷員工培訓和虛擬對練
格隆匯3月10日丨君實生物(688180.SH)在互動平臺表示,公司的數字化轉型始終貫徹“價值導向、務實創新”的基本原則,確保每項數字化投入均對應可量化的業務價值產出,通過AI技術的戰略性部署實現降本增效與業務創新雙重目標。因此2024年公司選擇了一個積極且務實的策略推動AI技術在公司落地,公司訓練部署了基於大模型技術的AI翻譯平臺,已替換80%以上科學文獻、臨牀試驗、質量管理、知識產權等各領域的文檔翻譯的外部服務。公司上線了基於AI大模型和知識庫的數字員工“i小君”爲一線銷售提供醫學信息問答,爲員工提供IT系統支持,HR和財務政策解答,文獻內容總結,內部知識庫查詢等服務。公司上線了基於7大國際市場GxP法規體系的GxP法規通,爲公司各相關業務領域提供法規知識問答。公司還開發了基於臨牀eTMF數據的KQI AI自動分析實現臨牀試驗電子文檔合規性自動監測,極大提升文檔提交和審覈的及時性。公司啓用智能會議紀要和待辦生成提升每天近千場線上會議的協作效率。 公司接入Deepseek後,進一步試點營銷員工培訓和虛擬對練,基於QMS以及外部質量數據庫的AI質量回顧和偏差分析和預測,批量處理數據,臨牀CRA文件自動採集和歸檔,統計編程助手等場景應用,探索臨牀和申報文檔輔助撰寫,科研文獻檢索和摘要,CI信息收集整理和分析等輕量級的AI研發輔助,持續提升研發效率與運營質量。同時公司規劃、佈局中長期戰略,逐步搭建和完善多組學數據平臺,構建企業知識圖譜,治理研發數據,夯實數據基礎,積極與學術機構、AI製藥公司合作,探索通過AI攻堅研發核心,加速靶點發現和驗證,分子設計,毒性預測等,加速藥物發現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.